1. Development and External Validation of Nomograms To Predict Adverse Pathological Characteristics After Robotic Prostatectomy: Results of a Prospective, Multi-institutional, Nationwide series 
Lorenzo Tosco, Greet De Coster, Thierry Roumeguère, Wouter Everaerts, Thierry Quackels, Peter Dekuyper, Ben Van Cleynenbreugel, Nancy Van Damme, Elizabeth Van Eycken, Filip Ameye, Steven Joniau 
European Urology Oncology 
Volume 1, Issue 4, Pages (September 2018)
DOI: /j.euo
Copyright © Terms and Conditions

2. Fig. 1
Flow diagram of the exclusion criteria to determine different analytical data sets. iPSA=initial prostate-specific antigen; bGS=biopsy Gleason score; EPE=extraprostatic extension; SVI=seminal vesicle invasion; HGLA=high-grade locally advanced disease.
European Urology Oncology 2018 1, DOI: ( /j.euo )
Copyright © Terms and Conditions

3. Fig. 2
EPE (extraprostatic disease) nomogram with receiver operating characteristic curve (area under the curve 0.76) and calibration plot based on the test cohort.
European Urology Oncology 2018 1, DOI: ( /j.euo )
Copyright © Terms and Conditions

4. Fig. 3
SVI (seminal vesicle invasion) nomogram with receiver operating characteristic curve (area under the curve 0.79) and calibration plot based on the test cohort.
European Urology Oncology 2018 1, DOI: ( /j.euo )
Copyright © Terms and Conditions

5. Fig. 4
HGLA (high-grade locally advanced disease) nomogram with receiver operating characteristic curve (area under the curve 0.85) and calibration plot based on the test cohort.
European Urology Oncology 2018 1, DOI: ( /j.euo )
Copyright © Terms and Conditions